Utility of <sup>18</sup>F-fluoroestradiol PET / CT in the differential diagnosis of estrogen receptor-positive breast cancer: case series
Breast cancer is one of the most common female cancers and the leading cause of cancer death in women. The method of positron emission tomography, combined with computed tomography, makes it possible to assess not only anatomical and structural, but also metabolic changes in tumor tissue. The increa...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2021-09-01
|
Series: | Опухоли женской репродуктивной системы |
Subjects: | |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/847 |
_version_ | 1797876013234913280 |
---|---|
author | A. V. Parnas A. I. Pronin V. S. Ilyakov N. A. Meshcheryakova Z. Kh. Kamolova D. I. Nevzorov |
author_facet | A. V. Parnas A. I. Pronin V. S. Ilyakov N. A. Meshcheryakova Z. Kh. Kamolova D. I. Nevzorov |
author_sort | A. V. Parnas |
collection | DOAJ |
description | Breast cancer is one of the most common female cancers and the leading cause of cancer death in women. The method of positron emission tomography, combined with computed tomography, makes it possible to assess not only anatomical and structural, but also metabolic changes in tumor tissue. The increased accumulation of 18F-fluoroestradiol in the pathological focus correlates with the estrogen receptor-positive status of the tumor, which is confirmed by tissue immunohistochemistry studies. The receptor status of a tumor formation fundamentally affects the choice of therapeutic tactics. The presented clinical examples demonstrate the capabilities of positron emission tomography, combined with computed tomography, with 18F-fluoroestradiol in the diagnosis of the estrogen receptor-positive tumor lesions. |
first_indexed | 2024-04-10T01:55:27Z |
format | Article |
id | doaj.art-87f300d475984f2a838ba8925179efd5 |
institution | Directory Open Access Journal |
issn | 1994-4098 1999-8627 |
language | Russian |
last_indexed | 2024-04-10T01:55:27Z |
publishDate | 2021-09-01 |
publisher | ABV-press |
record_format | Article |
series | Опухоли женской репродуктивной системы |
spelling | doaj.art-87f300d475984f2a838ba8925179efd52023-03-13T08:44:38ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272021-09-0117210.17650/1994-4098-2021-17-2-75-80689Utility of <sup>18</sup>F-fluoroestradiol PET / CT in the differential diagnosis of estrogen receptor-positive breast cancer: case seriesA. V. Parnas0A. I. Pronin1V. S. Ilyakov2N. A. Meshcheryakova3Z. Kh. Kamolova4D. I. Nevzorov5ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииФГБУ «Национальный медицинский исследовательский центр онкологии им. Н. Н. Блохина» Минздрава РоссииФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииФГБУ «Национальный медицинский исследовательский центр онкологии им. Н. Н. Блохина» Минздрава РоссииФГБУ «Национальный медицинский исследовательский центр онкологии им. Н. Н. Блохина» Минздрава РоссииФГБУ «Национальный медицинский исследовательский центр онкологии им. Н. Н. Блохина» Минздрава РоссииBreast cancer is one of the most common female cancers and the leading cause of cancer death in women. The method of positron emission tomography, combined with computed tomography, makes it possible to assess not only anatomical and structural, but also metabolic changes in tumor tissue. The increased accumulation of 18F-fluoroestradiol in the pathological focus correlates with the estrogen receptor-positive status of the tumor, which is confirmed by tissue immunohistochemistry studies. The receptor status of a tumor formation fundamentally affects the choice of therapeutic tactics. The presented clinical examples demonstrate the capabilities of positron emission tomography, combined with computed tomography, with 18F-fluoroestradiol in the diagnosis of the estrogen receptor-positive tumor lesions.https://ojrs.abvpress.ru/ojrs/article/view/847пэт / кт18f-фэсрецепторы эстрогенарак молочной железы |
spellingShingle | A. V. Parnas A. I. Pronin V. S. Ilyakov N. A. Meshcheryakova Z. Kh. Kamolova D. I. Nevzorov Utility of <sup>18</sup>F-fluoroestradiol PET / CT in the differential diagnosis of estrogen receptor-positive breast cancer: case series Опухоли женской репродуктивной системы пэт / кт 18f-фэс рецепторы эстрогена рак молочной железы |
title | Utility of <sup>18</sup>F-fluoroestradiol PET / CT in the differential diagnosis of estrogen receptor-positive breast cancer: case series |
title_full | Utility of <sup>18</sup>F-fluoroestradiol PET / CT in the differential diagnosis of estrogen receptor-positive breast cancer: case series |
title_fullStr | Utility of <sup>18</sup>F-fluoroestradiol PET / CT in the differential diagnosis of estrogen receptor-positive breast cancer: case series |
title_full_unstemmed | Utility of <sup>18</sup>F-fluoroestradiol PET / CT in the differential diagnosis of estrogen receptor-positive breast cancer: case series |
title_short | Utility of <sup>18</sup>F-fluoroestradiol PET / CT in the differential diagnosis of estrogen receptor-positive breast cancer: case series |
title_sort | utility of sup 18 sup f fluoroestradiol pet ct in the differential diagnosis of estrogen receptor positive breast cancer case series |
topic | пэт / кт 18f-фэс рецепторы эстрогена рак молочной железы |
url | https://ojrs.abvpress.ru/ojrs/article/view/847 |
work_keys_str_mv | AT avparnas utilityofsup18supffluoroestradiolpetctinthedifferentialdiagnosisofestrogenreceptorpositivebreastcancercaseseries AT aipronin utilityofsup18supffluoroestradiolpetctinthedifferentialdiagnosisofestrogenreceptorpositivebreastcancercaseseries AT vsilyakov utilityofsup18supffluoroestradiolpetctinthedifferentialdiagnosisofestrogenreceptorpositivebreastcancercaseseries AT nameshcheryakova utilityofsup18supffluoroestradiolpetctinthedifferentialdiagnosisofestrogenreceptorpositivebreastcancercaseseries AT zkhkamolova utilityofsup18supffluoroestradiolpetctinthedifferentialdiagnosisofestrogenreceptorpositivebreastcancercaseseries AT dinevzorov utilityofsup18supffluoroestradiolpetctinthedifferentialdiagnosisofestrogenreceptorpositivebreastcancercaseseries |